ML161

Catalog No.S2916

ML-161 is an allosteric inhibitor of PAR1 with IC50 of 0.26 μM.

Price Stock Quantity  
In DMSO USD 190 In stock
USD 147 In stock
USD 470 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

ML161 Chemical Structure

ML161 Chemical Structure
Molecular Weight: 361.23

Validation & Quality Control

Quality Control & MSDS

Related Compound Libraries

ML161 is available in the following compound libraries:

Product Information

Product Description

Biological Activity

Description ML-161 is an allosteric inhibitor of PAR1 with IC50 of 0.26 μM.
In vitro ML-161 is an allosteric inhibitor of PAR1. ML-161 displays dose-dependent inhibition of thrombin-induced platelet activation, as measured by P-selectin expression. ML-161 displays selective inhibition of SFLLRN and thrombin-induced platelet aggregation, both of which operate via PAR1, and has no effect on AYPGKF, thromboxane, or ADP-induced platelet aggregation, which are all agonists at alternative platelet GPCRs. [1]
In vivo
Features

Protocol(Only for Reference)

Kinase Assay: [2]

P-Selectin Expression Assay Blood from healthy donors who has not ingested aspirin in the 2 weeks prior to donation is collected by venipuncture into 0.4% sodium citrate. Citrate-anticoagulated blood is centrifuged at 200g for 20 minutes to prepare platelet-rich plasma. Washed platelets are subsequently prepared from platelet-rich plasma by centrifugation at 1,000g in the presence of 0.15 μM PGE1. For analysis of P-selectin expression, 20 μL washed platelets (0.5-1 × 108/mL) are incubated with the indicated agonists. Platelet activation is measured by P-selectin surface expression using PE-antihuman P-selectin and flow cytometry. Results are expressed as percent inhibition of P-selectin surface expression.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesBaboonDogMonkeyRabbitGuinea pigRatHamsterMouse
Weight (kg)121031.80.40.150.080.02
Body Surface Area (m2)0.60.50.240.150.050.0250.020.007
Km factor202012128653
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Dockendorff C, et al. ACS Med Chem Lett, 2012, 3(3), 232-237.

Chemical Information

Download ML161 SDF
Molecular Weight (MW) 361.23
Formula

C17H17BrN2O2

CAS No. 423735-93-7
Storage 3 years -20℃Powder
6 months-80℃in DMSO
Synonyms
Solubility (25°C) * In vitro DMSO 72 mg/mL (199 mM)
Water <1 mg/mL (<1 mM)
Ethanol <1 mg/mL (<1 mM)
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name Benzamide, 2-bromo-N-[3-[(1-oxobutyl)amino]phenyl]-

Research Area

Tech Support & FAQs

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related Others Products

  • (S)-crizotinib

    (S)-crizotinib, the (S)-enantiomer of crizotinib, is a potent MTH1 (NUDT1) inhibitor with IC50 of 72 nM.

  • PTC-209

    PTC-209 is a potent and selective BMI-1 inhibitor with IC50 of 0.5 μM, and results in irreversible reduction of cancer-initiating cells (CICs).

  • AZ191

    AZ191 is a potent and selective DYRK1B inhibitor with IC50 of 17 nM, about 5- and 110-fold selectivity over DYRK1A and DYRK2, respectively.

  • CX-4945 (Silmitasertib)

    CX-4945 (Silmitasertib) is a potent and selective inhibitor of CK2 (casein kinase 2) with IC50 of 1 nM, less potent to Flt3, Pim1 and CDK1 (inactive in cell-based assay). Phase 1/2.

    Features:First clinical inhibitor of CK2.

  • Tacrolimus (FK506)

    FK-506 is a 23-membered macrolide lactone, it reduces peptidyl-prolyl isomerase activity by binding to the immunophilin FKBP12 (FK506 binding protein) creating a new complex.

  • Verteporfin

    Verteporfin is a potent second-generation photosensitizing agent derived from porphyrin.

  • Bendamustine HCl

    Bendamustine HCL is a DNA-damaging agent with IC50 of 50 μM.

  • Cyclophosphamide Monohydrate

    Cyclophosphamide Monohydrate is a nitrogen mustard alkylating agent, it attaches the alkyl group to the guanine base of DNA.

  • Cyclosporin A

    Cyclosporin A is an immunosuppressive agent, binds to the cyclophilin and then inhibits calcineurin with IC50 of 7 nM, widely used in organ transplantation to prevent rejection.

  • Cabazitaxel

    Cabazitaxel (XRP6258) is a semi-synthetic derivative of a natural taxoid.

    Features:A semi-synthetic derivative of a natural taxoid.

Recently Viewed Items

Tags: buy ML161 | ML161 supplier | purchase ML161 | ML161 cost | ML161 manufacturer | order ML161 | ML161 distributor
Contact Us